Tibet Rhodiola Pharmaceutical (600211.SHG) Q4 2024 Earnings

30OctConfirmed
Apr 22
Q2 2024
Q3 2024
Q4 2024
0.7
1.04
1.37
1.7

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

Tibet Rhodiola Pharmaceutical (600211.SHG) will report earnings of for Q4 2024 on October 30, 2024.

0 Comments

Share your thoughts